A Phase II Study of Oral JAK1/JAK2 Inhibitor INC424 in Adult Patients With Relapsed/Refractory Classical Hodgkin's Lymphoma
Clinical trial NCT01877005 · COMPLETED
Trial details
- NCT number
- NCT01877005
- Sponsor
- The Lymphoma Academic Research Organisation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-04
- Primary completion
- 2015-06-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.